Case Reports in Pulmonology · Published 2025-01-01 · DOI 10.1155/crpu/8402905
A variety of conditions have been associated with acute fibrinous and organizing pneumonia (AFOP), including autoimmune disorders, infectious agents, posttransplantation complications, and medications. Everolimus, an oral selective inhibitor of the mammalian target of rapamycin, is commonly used to manage metastatic malignancies such as breast cancer. Here, we describe a patient with a history of advanced breast cancer who developed AFOP secondary to everolimus, with the condition improving following discontinuation of the drug and initiation of steroid therapy.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →